Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm

Human Pathology

Volumn 42, Issue 3, 2011, Pages 324-331

  Zhang, Lizhi ^a   Lohse, Christine M ^a   Dao, Linda N ^a   Smyrk, Thomas C ^a  

^a MAYO CLINIC   (United States)

Author keywords

CK19; Histopathology; KIT; Pancreatic endocrine neoplasm

Indexed keywords

AMYLOID; CD19 ANTIGEN; TUMOR MARKER; TUMOR MARKER KIT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS; PANCREAS ISLET CELL TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ISLET CELL; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; MINNESOTA; MITOSIS; NECROSIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79951578410     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.09.002     Document Type: Article

References (18)

1. DeLellis R.A.L.R., Heitz P.U., and Eng C. Pathology & Genetics, Tumors of Endocrine Organs 2004
2. Capella C., Heitz P.U., Hofler H., Solcia E., and Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut Virchows Arch 425 1995 547 560
3. Heymann M.F., Joubert M., and Nemeth J. Prognostic and immunohistochemical validation of the Capella classification of pancreatic neuroendocrine tumours: an analysis of 82 sporadic cases Histopathology 36 2000 421 432 (Pubitemid 30311624)
4. Schmitt A.M., Anlauf M., and Rousson V. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors Am J Surg Pathol 31 2007 1677 1682 (Pubitemid 350287565)
5. Schindl M., Kaczirek K., Kaserer K., and Niederle B. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 24 2000 1312 1318
6. Ferrone C.R., Tang L.H., and Tomlinson J. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 25 2007 5609 5615
7. Deshpande V., Fernandez-del Castillo C., and Muzikansky A. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors Am J Surg Pathol 28 2004 1145 1153 (Pubitemid 39121608)
8. Hochwald S.N., Zee S., and Conlon K.C. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups J Clin Oncol 20 2002 2633 2642 (Pubitemid 34575635)
9. Rindi G., de Herder W.W., O'Toole D., and Wiedenmann B. Consensus guidelines for the management of patients with digestive neuroendocrine tumors: why such guidelines and how we went about It Neuroendocrinology 84 2006 155 157 (Pubitemid 46361048)
10. Zhang L., Smyrk T.C., and Oliveira A.M. KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers Am J Surg Pathol 33 2009 1562 1569
11. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111 (Pubitemid 33041634)
12. Klimstra D.S.M.I., Adsay N.V., and Chetty R. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set Am J Surg Pathol 34 2010 300 313
13. Klimstra, DS, Modlin, IR, Coppola, D, Lloyd, RV and Suster, S, The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39:707-12.
14. La Rosa S., Klersy C., and Uccella S. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors Hum Pathol 40 2009 30 40
15. Ohike N., and Morohoshi T. Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation Pathol Int 51 2001 770 777 (Pubitemid 33078395)
16. Rahman A., Maitra A., Ashfaq R., Yeo C.J., Cameron J.L., and Hansel D.E. Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms Am J Clin Pathol 120 2003 685 690 (Pubitemid 37339674)
17. Goto A., Niki T., Terado Y., Fukushima J., and Fukayama M. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs) Histopathology 45 2004 384 392 (Pubitemid 39430643)
18. Ali A., Serra S., Asa S.L., and Chetty R. The predictive value of CK19 and CD99 in pancreatic endocrine tumors Am J Surg Pathol 30 2006 1588 1594 (Pubitemid 44808796)